The replication-associated (Rep) protein of porcine circovirus (PCV) was suggested to play an essential role in the replication and translation of viral DNA. In this study, one monoclonal antibody (mAb) specific for Rep protein of porcine circovirus type 1 (PCV1), two mAbs against Rep protein of porcine circovirus type 2 (PCV2), and five mAbs to both Rep protein of PCV1 and PCV2 were generated using, respectively, Rep protein of PCV1 and PCV2 expressed in Escherichia coli as an immunogen. Western blot analysis showed that native Rep protein of PCV2 virions appeared in two forms with different molecular weight in PCV2-infected cells. Laser confocal analyses further exhibited that Rep protein distributed mainly in the cellular nucleoplasm at the early stage of PCV2 infection, and moved to the nuclear periphery and the cytoplasm at the last stage of PCV2 infection. The results from this study confirmed that Rep protein of PCV2 distributed in both nucleus and cytoplasm, and provided an mAb tool to further analyze replications of PCV1 and PCV2 in vitro and in vivo.
Introduction
T he porcine circovirus (PCV) is 17 nm in diameter, is icosahedral, is a nonenveloped virion with singlestranded DNA genome (Tischer et al., 1982) , and belongs to the circoviridae family. Two phenotypically distinct PCVs, porcine circovirus type 1 (PCV1) and type 2 (PCV2), have been described to date (Fenaux et al., 2000) . PCV1, a nonpathogenic PCV in swine, was detected in 1974 in a porcine kidney cell line as a persistent cell culture contaminant (Tischer et al., 1982) . In contrast, PCV2 is associated with the postweaning multisystemic wasting syndrome (Allan et al., 1998; Allan and Ellis, 2000) . PCV2 has also been increasingly reported in pigs with different clinical conditions such as porcine dermatitis and nephropathy syndrome (Rosell et al., 2000) , congenital tremors (Stevenson et al., 2001) , late-term abortion (West et al., 1999) , and exudative epidermitis (Wattrang et al., 2002) . The above-mentioned diseases were designated PCV disease (Segales et al., 2005) or PCV2-associated disease (Opriessnig et al., 2007) .
The genomic sequences of PCV1 and PCV2 isolates have been determined, and their genomes share 68-76% sequence homology (Mankertz et al., 2004) . Intragenotype isolates of PCV1 and PCV2 share 97-99% and 96.4-99% sequence homology, respectively (Fenaux et al., 2000; de Boisseson et al., 2004 ). There are two major proteins in a PCV virion: replication (Rep) and capsid (Cap) proteins. Rep protein, with a molecular weight of 35.7 kDa, is a replication-associated protein, and highly conserved in all circoviruses (Mankertz et al., 1998) . Cap protein is the major immunogenic protein with a molecular weight of 27.8 kDa (Nawagitgul et al., 2000; Cheung, 2003b) . Recently, a novel protein involving in viral pathogenesis, encoded by ORF3, has been identified in vitro (Liu et al., 2005 (Liu et al., , 2006 . During PCV duplication, Rep and Rep 0 (a differentially spliced Rep transcript) can form homometric and heterometric complexes, and are essential for initiation of DNA replication; one of them alone is unable to promote initiation of DNA replication (Steinfeldt et al., 2001; Cheung, 2003a; Mankertz et al., 2004) .
Monoclonal antibodies (mAb) against PCV1 and PCV2 have been produced (Allan et al., 1994 (Allan et al., , 1998 , but these mAbs were not demonstrated to be anti-Rep or anti-Cap. Subsequently, mAbs against Cap protein of PCV2 were also produced, and utilized to identify antigenic differences and epitope of PCV2 (Lekcharoensuk et al., 2004; Zhou et al., 2005) . Rep protein is the catalytic components of PCV replication. Availability of specific antibodies against Rep protein may facilitate further studies of viral replication and biosynthesis. In this study, we expressed Rep protein of PCV in Escherichia coli as a fusion protein with his tag, prepared mAbs against Rep protein of PCV, and investigated the intracellular distribution of Rep protein of PCV2 using the antibodies.
Materials and Methods

Virus, cells, and serum
The PCV1 strain (AY193712) and PCV2 isolate HZ0201 (AY188355) were stored in our laboratory . PCV1-free PK15 cells were grown in modified Eagle's medium (Invitrogen, Grand Island, NY) supplemented with 10% fetal bovine serum (GibcoBRL Life Technologies, Grand Island, NY) at 378C. Chicken anti-PCV1 serum was kindly provided by Prof. John McKillen from Agri-Food and Biosciences Institute for Northern Ireland, United Kingdom. Swine anti-PCV2 serum was prepared in our laboratory (Shang et al., 2008) .
Construction of expression vectors
The 939-bp DNA fragment encoding Rep protein of PCV1 and the 945-bp DNA fragment encoding Rep protein of PCV2 were amplified, respectively, using the specific primers as follows: 5 0 -TAGAATTCATGCCAAGCAAGAAAG-3 0 and 5 0 -GGCAAGCTTTCAGTAATTTATTTTATATGG-3 0 (PCV1); 5 0 -GCGAATTCATGCCCAGCAAGAAGAA-3 0 and 5 0 -GGC AAGCTTTCAGTAATTTATTTCATATGG-3 0 (PCV2). PCR was performed by predenaturing at 948C for 3 min, denaturing at 948C for 45 s, annealing at 558C for 45 s, and extending at 728C for 1.5 min for 30 cycles, with a final elongation step for 10 min at 728C. Subsequently, PCR products were subcloned into a prokaryotic expression pET-28a (þ) vector (Novagen, Madison, WI). The recombinant expression plasmids, designated as pET-PCV1-Rep and pET-PCV2-Rep, were then confirmed by PCR, restriction enzyme digest, and DNA sequencing.
To construct the eukaryotic expression vector, the 945-bp DNA fragment of rep gene for PCV2 was amplified using the above-mentioned PCR procedure with the following primers: 5 0 -CACTCGAGATGCCCAGCAAGAAGAATG-3 0 and 5 0 -CGCGAATTCTCAGTAATTTATTTCATATGGA-3 0 . The recombinant plasmid, designated as pEGFP-PCV2-Rep, was constructed by subcloning into an eukaryotic expression pEGFP-C3 vector (Clontech, Palo Alto, CA).
Expression and purification of Rep protein
The E. coli BL21 (DE3) strains containing pET-PCV1-Rep of and pET-PCV2-Rep plasmid were propagated at 378C for 4 h for Rep protein, under induction of 1 mM isopropyl-b-Dthiogalactopyranoside (IPTG). Bacterial culture was collected and centrifuged at 12,000 g for 30 min at 48C. The resultant pellets were resuspended with 1=10 volume of buffer B (100 mM NaH 2 PO 4 Á 2H 2 O, 10 mM Tris-base, and 8 M Urea, pH 8.0) and then sonicated on ice. After centrifugation at 12,000 g for 30 min at 48C, the supernatant was collected and purified by Ni-NTA affinity chromatograph column (Novagen) according to the manufacturer's protocol. The purified protein was detected by SDS-PAGE and western blot using mouse anti-his antibody (Amersham, Buckinghamshire, UK). Total protein concentration was determined by the Bradford method (Bradford, 1976 ) using bovine serum albumin as a reference.
Production and characterization of mAbs against Rep protein
Three SPF BALB=c mice were immunized intraperitoneally and subcutaneously with Rep (50 mg Rep per mouse) emulsified in complete Freund's adjuvant (Sigma-Aldrich, St. Louis, MO). The mice were boosted with Rep (50 mg per mouse) emulsified in incomplete Freund's adjuvant (SigmaAldrich) 2 weeks after the first immunization. Two weeks after the second immunization, the vaccinated mice were injected intraperitoneally with a dose of 0.1 mg of the purified Rep again. The mice were subsequently euthanized 3 days later, and the spleen cells were harvested. The spleen cells were fused with SP2=0 cells as described previously (Kohler and Milstein, 1975) . The hybridoma cells were cultured in RPMI-1640 containing HAT and HT for 10-14 days. The hybridomas secreting antibodies against Rep were confirmed by the indirect ELISA as described previously (Zheng et al., 2006) . The positive cells were cloned three times by limiting dilution. The IgG subtype analysis of each mAb was performed using an SBA Clonotyping System=HRP (Southern Biotechnology Associates, Birmingham, AL). Then, the interesting cells were propagated, suspended in serum-free medium, and then inoculated into the pristine-primed mice. Finally, the ascetic fluids containing mAbs were collected 7-10 days postinoculation. Reactivity and titer of mAbs to Rep proteins were tested by western blot and ELISA using the homologous Rep protein, respectively.
Cross reaction and binding analysis of the mAbs with Rep protein of PCV1 and PCV2
To ascertain the reactivity of mAbs with the native protein from PCV virions, PCV1-and PCV2-infected PK15 monolayer was prepared at a multiplicity of infection (MOI) of 1 as described previously (Zhou et al., 2005) . Then, cross reactivity of the mAbs was detected using the methods of IFA as previously described (Zhou et al., 2005) . Briefly, the cells were washed twice with PBS, fixed with cold acetone=methanol (1:1) for 30 min at À208C, and then allowed to air dry. The fixed cells were incubated with mAbs for 60 min at 378C in a humidified chamber. After washing three times with PBST, the cells were incubated for 60 min at 378C with an FITC-conjugated goat anti-mouse IgG (KPL, Gaithersburg, MD). The stained cells were washed three times with PBST and photographed under the laser confocal microscope (Zeiss, Gö ttingen, Germany). PCV1-and PCV2-infected PK15 cells were harvested at 48 h postinoculation, and lysed on ice using cell lysis solution (7 M urea, 2 M thiourea, 40 mM TrisBase, and 1 mM phenylmethylsulphonylfluoride). The harvested supernatant was subjected to western blot analysis with mAbs against Rep protein. The mock-infected CEF and Vero cells were used as negative controls.
Subcellular localization of Rep protein of PCV2
The recombinant plasmid pEGFP-PCV2-Rep for transfection was purified using the high-purity plasmid Miniprep system (Marligen Bioscience, Heidelberg, Germany) in accordance with the manufacturer's protocol. The transfection was performed with some modification according to the instruction manual of LipofectamineÔ 2000 reagent (Invitrogen) in 96-well plates. PK15 cell monolayer grown to 95% 24 ZHANG ET AL.
confluence was transfected with 0.2 mg of pEGFP-PCV2-Rep and 0.6 mL Lipofectamine 2000 reagent diluted in 25 mL MEM without serum and antibiotics. PCV2-infected PK15 cells were prepared using the above-mentioned method. The transfected and infected cells were cultured, respectively, for 24, 48, and 72 h. The infected cells were fixed and incubated with mAb 3B1 to Rep protein of PCV2 for 60 min at 378C. After washing three times with PBST, the cells were incubated for 60 min at 378C with an FITC-conjugated goat antimouse IgG (KPL). The stained cells were washed three times with PBST. Finally, the transfected and infected cells were examined under the laser confocal microscope.
ELISA additivity tests for epitope identification of mAbs against Rep protein ELISA additivity test was performed to analyze the epitopes of mAbs as described previously (Friguet et al., 1983) with some modification. Ninety-six-well plates were coated with the purified PCV Rep protein at a concentration of 40 ng per well. The mAbs were serially diluted from 25-fold to 51,200-fold. HRP-labeled goat anti-mouse IgG at 1:3000 dilution was added and incubated for 1 h at 378C. Based on the OD 450 values, curves of mAbs saturating the corresponding PCV Rep antigen were determined. The epitope of mAbs was then analyzed by adding mixtures of the two optimally diluted ascitic fluids, sufficient for each to saturate the coated antigen, and the bound mAbs were detected as above. To evaluate the additivity effect, an additivity index (AI) was calculated using the formula: AI ¼ [2A 1þ2 =(A 1 þ A 2 ) À 1]Â 100, where A 1 , A 2 , and A 1þ2 are the absorptions with the first antibody, second antibody, and two mAbs together, respectively. If two antibodies bind randomly at the same site, the AI value will tend to be 0; on the contrary, if the two antibodies bind independently at topographically unrelated sites, the AI value will be close to 100.
Results
Expression, purification, and identification of prokaryotic recombinant proteins
The rep gene of PCV1 and PCV2 was amplified by PCR and subcloned into the vector pET-28a (þ). After induction by 1 mM IPTG at 378C for 4 h, the recombinant His-Rep proteins, with a molecular weight of 40 kDa, were found in inclusion bodies. After purification by Ni-NTA affinity chromatography, the His-Rep proteins of PCV1 and PCV2 could be recognized by chicken anti-PCV1 serum and swine anti-PCV2 serum (Fig. 1A, B) in western blot analysis.
General characteristics of mAbs
After cell fusion and screening, three hybridomas secreting mAbs to His-Rep proteins of PCV1 and five hybridomas secreting mAbs to His-Rep proteins of PCV2 were established, designated as mAbs1B5, 1E1, and 3E12 to His-Rep of PCV1, and mAbs 2H10, 3A7, 3B1, 5D8, and 6H9 to His-Rep of PCV2. Immunoglobulin subtype analysis indicated that the heavy and light chains of all mAbs were IgG1 and k, respectively (Table 1) . When the recombinant Rep proteins were used as antigens, western blot analysis (Fig. 2) showed that one (mAb 1B5) of three mAbs originating from PCV1 His-Rep was specific for PCV1 Rep protein, two (mAbs 3B1 and 5D8) of five mAbs originating from PCV2 His-Rep were specific for PCV2 Rep protein, and the remained mAbs could react with both Rep proteins of PCV1 and PCV2. When native Rep protein from PCV1 and PCV2 particles was used as an antigen, in western blot analysis (Fig. 2) , only mAbs 2H10 and 6H9 to Rep protein of PCV2 could recognize native Rep protein from PCV2 virions, but the mAbs to Rep protein of PCV1 and the remaining mAbs to Rep protein of PCV2 did not react with Rep protein of PCV2. Interestingly, western blot analysis (Fig. 2) indicating that at least two molecular forms of Rep protein existed during PCV2 replication.
Reactivity of mAbs with native Rep protein
To detect reactivity and specificity of mAb to HisRep protein with native Rep protein of PCV virions, IFA analysis was conducted in PCV-infected PK15 cell monolayers. As shown in Figure 3 , the mAbs originating from PCV1 His-Rep protein and PCV2 His-Rep protein, can recognize the PK15 cell monolayer infected with PCV1 and PCV2, indicating that the mAb to Rep protein expressed in E. coli exhibited a binding ability with native Rep protein of PCV. However, only mAb 1B5 was specific for Rep protein of PCV1, mAbs 3B1 and 5D8 were specific for PCV2 Rep protein, and the remained mAbs detected Rep proteins of PCV1 and PCV2.
Localization of Rep protein of PCV2
To investigate the intracellular localization of PCV2 Rep protein, PK15 cell monolayers were inoculated with PCV2, and then cellular distribution of Rep protein was analyzed using the mAb to PCV2 Rep protein by laser confocal microscopy. Figure 4A demonstrates that the Rep protein of PCV2 was distributed in the nucleus of host cells at 24 to 48 h postinoculation. But at 72 h postinoculation, the Rep protein was concentrated in the nuclear membrane and moved to the cytoplasma. When PK15 cell monolayers were transfected with pEGFP-PCV2-Rep vectors, Rep protein was also expressed in the nucleus (Fig. 4B ) of the transfected cells at 24 to 48 h posttransfection, and moved to the cytoplasma at 72 h posttransfection.
Epitope analysis of mAbs
In the ELISA additivity test, the AI value was used to evaluate whether mAbs recognized the same or different antigenic sites (Portner et al., 1987) . In brief, AI >50 indicated that two mAbs had additivity effect and recognized different antigenic sites, while AI <50 suggested that two mAbs had no additivity effect and recognized the same or close antigenic sites. The AI values between pairs of mAbs are listed in Table 2 . Among the eight mAbs, the mAbs 3B1 and 1E1 may recognize the same epitope; the mAbs 3E12, 2H10, and 3A7 may recognize the same epitope; the mAbs 1B5, 5D8, and 6H9 possibly recognize three different epitopes.
Discussion
In the present study, we generated mAbs recognizing native PCV1 Rep protein, PCV2 Rep protein, and Rep proteins of PCV1 and PCV2, using recombinant Rep protein expressed in E. coli as an immunogen. Subsequently, by additivity ELISA, the eight generated mAbs were found to represent five different antigenic epitopes and the antigenic site recognized by the mAbs 1E1 and 1B5 may be partially overlapping. Thus, fine definition of antigenic epitopes needs to be performed by phage display and synthesizing peptides. In the present study, we generated the mAbs to provide a tool for discriminating PCV1 and PCV2 infections. Finsterbusch et al. (2005) analyzed the subcellular localization of Rep and Cap proteins of PCV1, and determined that Rep protein of PCV1 localized in the nucleus, and that there are three nuclear localization signals (NLS), NLS1, NLS2, and NLS3, in which NLS1 and NLS2 were required to mediate the nuclear import, while NLS3 merely enhanced the nuclear import of Rep. However, there are no reports about the localization of Rep protein of PCV2. In the present study, using the mAb to PCV2 Rep protein, we investigated the subcellular localization of Rep protein of PCV2. Our results showed that at 24 to 48 h postinoculation or posttransfection PCV2 Rep protein only appeared in the nucleus, which was same with subcellular localization of Rep protein of PCV1. But at 72 h postinoculation, the Rep protein mainly localized in the nuclear periphery and in the cytoplasm. This phenomenon was different from the Rep protein of PCV1 subcellular localization (Finsterbusch et al., 2005) , which may provide some insight into the difference between PCV1 and PCV2. Presently, we do not know why Rep protein of PCV2 appeared in the cytoplasm. However, the reported data showed the interaction between the Rep protein of PCV2 with the host cellular protein or PCV2 Cap protein (Timmusk et al., 2006) . Whether the interaction between Rep protein and Cap protein affects the localization of Rep protein of PCV2 needs further study. In addition, although we first found that two molecular forms of native Rep protein existed during PCV2 replication by western blot analysis, the role of different forms of Rep proteins needs further investigation during replication and pathogenicity of PCV2.
